FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Susan Chippari

Research Profile

Chemicals & Drugs

Living Beings

Concepts & Ideas

Structure-Activity Relationship

Anatomy

Cell Line

Disorders

Procedures

Administration, Oral

Co-author Network

Publications

TOP 3
Thomas J Caggiano; Antony Brazzale; Douglas M Ho; Christina M Kraml; Eugene Trybulski; Christopher C Chadwick; Susan Chippari; Lisa Borges-Marcucci; Amy Eckert; James Carl Keith; Thomas Kenney; Douglas C Harnish
Estrogen receptor dependent inhibitors of NF-kappaB transcriptional activation-1 synthesis and biological evaluation of substituted 2-cyanopropanoic acid derivatives: pathway selective inhibitors of NF-kappaB, a potential treatment for rheumatoid arthritis.
M R Yudt; Tom Berrodin; Scott Jelinsky; L A Hanna; Eugene L Brown; Susan Chippari; Ramesh A Bhat; Richard Winneker; Zhiming Zhang
Selective and opposing actions of progesterone receptor isoforms in human endometrial stromal cells.
Robert J Steffan; Edward Matelan; Mark A Ashwell; William J Moore; William R Solvibile; Eugene Trybulski; Christopher C Chadwick; Susan Chippari; Thomas Kenney; Richard Winneker; Amy Eckert; Lisa Borges-Marcucci; Steven J Adelman; Zhang Xu; Lidia Mosyak; Douglas C Harnish
Control of chronic inflammation with pathway selective estrogen receptor ligands.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Susan Chippari (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Thomas J Caggiano; Antony Brazzale; Douglas M Ho; Christina M Kraml; Eugene Trybulski; Christopher C Chadwick; Susan Chippari; Lisa Borges-Marcucci; Amy Eckert; James Carl Keith; Thomas Kenney; Douglas C Harnish
Estrogen receptor dependent inhibitors of NF-kappaB transcriptional activation-1 synthesis and biological evaluation of substituted 2-cyanopropanoic acid derivatives: pathway selective inhibitors of NF-kappaB, a potential treatment for rheumatoid arthritis.
Journal of medicinal chemistry 2007;50(22):5245-8.
2006: M R Yudt; Tom Berrodin; Scott Jelinsky; L A Hanna; Eugene L Brown; Susan Chippari; Ramesh A Bhat; Richard Winneker; Zhiming Zhang
Selective and opposing actions of progesterone receptor isoforms in human endometrial stromal cells.
Molecular and cellular endocrinology 2006;247(1-2):116-26.
2006: Robert J Steffan; Edward Matelan; Mark A Ashwell; William J Moore; William R Solvibile; Eugene Trybulski; Christopher C Chadwick; Susan Chippari; Thomas Kenney; Richard Winneker; Amy Eckert; Lisa Borges-Marcucci; Steven J Adelman; Zhang Xu; Lidia Mosyak; Douglas C Harnish
Control of chronic inflammation with pathway selective estrogen receptor ligands.
Current topics in medicinal chemistry 2006;6(2):103-11.
2005: Steven M Opal; John E Palardy; Patricia Cristofaro; Nicolas A Parejo; Jhung W Jhung; James Carl Keith; Susan Chippari; Thomas J Caggiano; Robert J Steffan; Christopher C Chadwick; Douglas C Harnish
The activity of pathway-selective estrogen receptor ligands in experimental septic shock.
Shock (Augusta, Ga.) 2005;24(6):535-40.
2005: Zhiming Zhang; Andrea M Olland; Yuan Zhu; Jeff Cohen; Tom Berrodin; Susan Chippari; Chandrasekaran Appavu; Shen Li; James Wilhem; Rajiv Chopra; Andrew Fensome; Puwen Zhang; Jay Wrobel; Rayomand J Unwalla; C Richard Lyttle; Richard Winneker
Molecular and pharmacological properties of a potent and selective novel nonsteroidal progesterone receptor agonist tanaproget.
The Journal of biological chemistry 2005;280(31):28468-75.
2005: Christopher C Chadwick; Susan Chippari; Edward Matelan; Lisa Borges-Marcucci; Amy M Eckert; James Carl Keith; Leo M Albert; Yelena Leathurby; Heather A Harris; Ramesh A Bhat; Mark A Ashwell; Eugene Trybulski; Richard Winneker; Steven J Adelman; Robert J Steffan; Douglas C Harnish
Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(7):2543-8.
2004: Robert J Steffan; Edward Matelan; Mark A Ashwell; William J Moore; William R Solvibile; Eugene Trybulski; Christopher C Chadwick; Susan Chippari; Thomas Kenney; Amy Eckert; Lisa Borges-Marcucci; James Carl Keith; Zhang Xu; Lidia Mosyak; Douglas C Harnish
Synthesis and activity of substituted 4-(indazol-3-yl)phenols as pathway-selective estrogen receptor ligands useful in the treatment of rheumatoid arthritis.
Journal of medicinal chemistry 2004;47(26):6435-8.